Q1 2025 Earnings Call Transcript May 5, 2025 Operator: Good day, everyone, and welcome to the Syndax First Quarter 2025 ...

Mark Andrew Lawson is a businessperson who founded ARMM, Inc. and Veritransfer, Inc. and who has been at the helm of 11 different companies. He occupies the position of President, Chief Executive ...

Q1 2025 Earnings Call Transcript May 8, 2025 Crinetics Pharmaceuticals, Inc. misses on earnings expectations. Reported EPS is ...

Pivotal Phase 3 LUCIDITY trial of avexitide, a potential first-in-class GLP-1 receptor antagonist with FDA breakthrough therapy designation, underway in post-bariatric hypoglycemia (PBH); completion ...

At this time, I would like to welcome everyone to the Amylyx Pharmaceuticals First Quarter Earnings Conference Call. All participants will be in a listen-only mode. After today’s presentation there ...

Pharmacy schools are accredited by the Accreditation Council for Pharmacy Education, a nonprofit agency that oversees schools ...

As of March 31, 2025, Aura had cash and cash equivalents and marketable securities totaling $128.0 million. The Company believes its current cash and cash equivalents and marketable securities are ...

The Oxygen Scavenger Market is growing steadily, driven by demand in food packaging, pharmaceuticals, and oil & gas sectors. Key players like Mitsubishi Gas Chemical, BASF SE, Clariant, and Arkema are ...

Hart is not the only one raising concerns about the deal. Former federal prosecutor Rick Mountcastle, who investigated Purdue ...

Positive results from Phase 3 trial for MaaT013 in acute Graft-versus-Host disease (aGvHD); topline results showed a 62% ...

British pharmaceutical company GSK(GSK) to acquire Boston Pharmaceuticals’ lead asset, efimosfermin alfa, for as much as $2 ...